Atorvastatin

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Arcadian (talk | contribs) at 21:03, 23 December 2005 (added "width=198" so image looks better). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Atorvastatin
Clinical data
Pregnancy
category
Routes of
administration
oral
ATC code
Legal status
Legal status
Pharmacokinetic data
Bioavailability12%
MetabolismLiver
Elimination half-life14 hours
ExcretionBile
Identifiers
  • [R-(R*, R*)]-2-(4-fluorophenyl)-beta, delta-dihydroxy-5- (1-methylethyl)-3-phenyl-4- [(phenylamino)carbonyl]-1H- pyrrole-1-heptanoic acid
CAS Number
PubChem CID
DrugBank
CompTox Dashboard (EPA)
ECHA InfoCard100.125.464 Edit this at Wikidata
Chemical and physical data
Formula(C33H34FN2O5)2Ca•3H2O
Molar mass1209.42

In medicine and pharmacology, atorvastatin is a member of the drug class of statins, used for lowering cholesterol and thereby preventing cardiovascular disease. Atorvastatin inhibits a rate-determining enzyme located in hepatic tissue used in cholesterol synthesis, which lowers the amount of cholesterol produced. This also has the effect of lowering the total amount of LDL cholesterol.

Unlike simvastatin and pravastatin, atorvastatin is a completely synthetic compound.

File:Lipitor.gif

Atorvastatin is currently marketed by the pharmaceutical company Pfizer as Lipitor®. With 2004 sales of US$10.9 billion, it is the best selling drug in the world.

Available forms

Atorvastatin is available as Lipitor in tablet form (10, 20, 40 or 80 mg) for oral administration. Tablets are white, elliptical, and film coated.

Mechanism of action

Atorvastatin is a competitive inhibitor of HMG-CoA reductase. This enzyme catalyzes the reduction of 3-hydroxy-3-methylglutaryl-coenzyme A to mevalonate, which is the rate limiting step in hepatic cholesterol synthesis.

Because cholesterol synthesis decreases, hepatic cells increase the number of LDL receptors on the surface of the cells, which increase the amount of LDL uptake by the hepatic cells, and decreases the amount of LDL in the blood.

References

  1. Maggon, Krishan. "Best-selling human medicines 2002-2004 (editorial)". 2005. Drug Discovery Today, 10(11):739-742. [1]
  2. Lipitor: Prescribing Information. (2004) Pfizer Ireland Pharmaceuticals.

External links